Skip to main content

Protagonist Therapeutics, Inc 10-Q for FY2024 Q3

Protagonist Therapeutics, Inc (PTGX)

10-Q 2024-11-07 For: 2024-09-30
View Original
Added on April 07, 2026

About this 10-Q

Protagonist Therapeutics, Inc filed this 10-Q on November 7, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$4.68M
compared with $0 a year earlier
Net loss
$33.21M
compared with a net loss of $34.11M a year earlier
Diluted EPS
-$0.54
compared with -$0.58 a year earlier